Article Text

other Versions

Download PDFPDF
Post hoc analysis of RCT
Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetes
  1. Francesco Giorgino
  1. Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Piazza Giulio Cesare, 11, Bari 70124, Italy;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


The glycaemic portion of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed that an intensive glucose-lowering strategy may increase overall and cardiovascular (CV) mortality, as compared with a standard management.1 However, it is unclear whether age may influence the effects of intensive glycaemic control. Answering this question is of particular relevance since: (1) diabetes prevalence in individuals over 65 years is increasing; (2) the characteristics of diabetes in the elderly may differ from those in younger patients and (3) limited information is available in the elderly population since it is poorly represented in most diabetes trials.


This is a retrospective subgroup analysis on the ACCORD trial dataset, assessing …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.